Publicaciones en las que colabora con MARÍA LUISA CAÑADAS GARRE (15)

2021

  1. Pharmacogenetic Predictors of Response to Interferon Beta Therapy in Multiple Sclerosis

    Molecular Neurobiology, Vol. 58, Núm. 9, pp. 4716-4726

2020

  1. Association of ABCB1 and VEGFA gene polymorphisms with breast cancer susceptibility and prognosis

    Pathology Research and Practice, Vol. 216, Núm. 4

  2. Effect of DPYD, MTHFR, ABCB1, XRCC1, ERCC1 and GSTP1 on chemotherapy related toxicity in colorectal carcinoma

    Surgical Oncology, Vol. 35, pp. 388-398

2019

  1. Impact of single nucleotide polymorphisms on the efficacy and toxicity of EGFR tyrosine kinase inhibitors in advanced non-small cell lung cancer patients

    Mutation Research - Reviews in Mutation Research, Vol. 781, pp. 63-70

  2. Pharmacogenetics of platinum-based chemotherapy: impact of DNA repair and folate metabolism gene polymorphisms on prognosis of non-small cell lung cancer patients

    Pharmacogenomics Journal, Vol. 19, Núm. 2, pp. 164-177

2018

  1. Impact of DNA repair, folate and glutathione gene polymorphisms on risk of non small cell lung cancer

    Pathology Research and Practice, Vol. 214, Núm. 1, pp. 44-52

2017

  1. Contribution of genetic factors to platinum-based chemotherapy sensitivity and prognosis of non-small cell lung cancer

    Mutation Research - Reviews in Mutation Research, Vol. 771, pp. 32-58

  2. Cytokine single-nucleotide polymorphisms and risk of non-small-cell lung cancer

    Pharmacogenetics and Genomics, Vol. 27, Núm. 12, pp. 438-444

  3. Interleukins as new prognostic genetic biomarkers in non-small cell lung cancer

    Surgical Oncology, Vol. 26, Núm. 3, pp. 278-285

2016

  1. Liquid biopsy in early stage lung cancer

    Translational Lung Cancer Research, Vol. 5, Núm. 5, pp. 517-524

  2. Pharmacogenetic predictors of toxicity to platinum based chemotherapy in non-small cell lung cancer patients

    Pharmacological Research, Vol. 111, pp. 877-884

2015

  1. MET/HGF targeted drugs as potential therapeutic strategies in non-small cell lung cancer

    Pharmacological Research, Vol. 102, pp. 90-106

  2. MET: A new promising biomarker in non-small-cell lung carcinoma

    Pharmacogenomics, Vol. 16, Núm. 6, pp. 631-647

  3. PTEN and PI3K/AKT in non-small-cell lung cancer

    Pharmacogenomics, Vol. 16, Núm. 16, pp. 1843-1862

2013

  1. Pharmacogenetics of oral anticoagulants

    Omics for Personalized Medicine (Springer India), pp. 435-467